Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 8
1787 6
1788 2
1789 2
1790 6
1791 2
1792 3
1793 4
1794 3
1795 5
1797 6
1799 20
1800 26
1801 11
1802 3
1803 5
1804 4
1805 9
1806 6
1807 8
1808 4
1809 5
1810 9
1811 3
1812 7
1813 4
1814 9
1815 4
1816 7
1817 7
1818 16
1819 4
1820 9
1821 9
1822 9
1823 9
1824 8
1825 12
1826 50
1827 65
1828 34
1829 46
1830 47
1831 49
1832 40
1833 28
1834 22
1835 15
1836 16
1837 17
1838 89
1839 49
1840 38
1841 110
1842 95
1843 60
1844 79
1845 59
1846 65
1847 68
1848 42
1849 80
1850 77
1851 77
1852 97
1853 86
1854 64
1855 93
1856 170
1857 245
1858 205
1859 180
1860 116
1861 113
1862 110
1863 91
1864 119
1865 80
1866 150
1867 127
1868 135
1869 159
1870 138
1871 158
1872 151
1873 137
1874 130
1875 102
1876 85
1877 95
1878 70
1879 90
1880 84
1881 87
1882 100
1883 132
1884 96
1885 67
1886 264
1887 833
1888 869
1889 908
1890 1070
1891 823
1892 971
1893 1059
1894 1082
1895 995
1896 894
1897 1056
1898 1162
1899 1104
1900 1120
1901 1082
1902 1175
1903 1108
1904 1149
1905 1183
1906 978
1907 1295
1908 1268
1909 1219
1910 1245
1911 1178
1912 1062
1913 1114
1914 1172
1915 945
1916 977
1917 886
1918 1036
1919 1144
1920 1497
1921 1011
1922 195
1923 228
1924 304
1925 223
1926 239
1927 313
1928 270
1929 246
1930 338
1931 298
1932 332
1933 310
1934 314
1935 295
1936 288
1937 311
1938 336
1939 319
1940 291
1941 265
1942 244
1943 287
1944 220
1945 535
1946 1365
1947 1317
1948 1202
1949 1061
1950 1887
1951 2378
1952 2466
1953 2606
1954 2389
1955 2234
1956 2402
1957 2294
1958 2559
1959 2688
1960 2747
1961 2817
1962 2916
1963 3655
1964 4495
1965 4713
1966 5122
1967 5087
1968 6386
1969 7012
1970 7196
1971 7090
1972 7681
1973 7680
1974 8359
1975 10338
1976 10705
1977 10959
1978 13176
1979 14318
1980 13655
1981 13712
1982 14458
1983 16268
1984 16571
1985 17919
1986 18717
1987 34133
1988 54270
1989 58981
1990 67849
1991 69553
1992 71994
1993 75090
1994 76885
1995 80584
1996 81656
1997 85178
1998 87952
1999 90361
2000 93932
2001 96534
2002 100106
2003 107114
2004 113950
2005 124966
2006 134313
2007 142142
2008 153097
2009 163302
2010 176847
2011 194401
2012 213783
2013 245986
2014 311550
2015 356140
2016 381735
2017 403535
2018 426204
2019 460731
2020 564101
2021 631906
2022 632480
2023 595179
2024 220379

Text availability

Article attribute

Article type

Publication date

Search Results

7,455,786 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic Properties of Dapagliflozin in Hemodialysis and Peritoneal Dialysis Patients.
Barreto J, Borges C, Rodrigues TB, Jesus DC, Campos-Staffico AM, Nadruz W, Luiz da Costa J, Bueno de Oliveira R, Sposito AC. Barreto J, et al. Clin J Am Soc Nephrol. 2023 Aug 1;18(8):1051-1058. doi: 10.2215/CJN.0000000000000196. Epub 2023 May 25. Clin J Am Soc Nephrol. 2023. PMID: 37227937
No serious adverse events were reported for either group. Dapagliflozin recovered from dialysate corresponded to 0.10% of the administered dose. CONCLUSIONS: In patients with kidney failure on dialysis, dapagliflozin was well tolerated, was slightly dialyzable …
No serious adverse events were reported for either group. Dapagliflozin recovered from dialysate corresponded to 0.10% of the adminis …
Renal Association Clinical Practice Guideline on Haemodialysis.
Ashby D, Borman N, Burton J, Corbett R, Davenport A, Farrington K, Flowers K, Fotheringham J, Andrea Fox RN, Franklin G, Gardiner C, Martin Gerrish RN, Greenwood S, Hothi D, Khares A, Koufaki P, Levy J, Lindley E, Macdonald J, Mafrici B, Mooney A, Tattersall J, Tyerman K, Villar E, Wilkie M. Ashby D, et al. BMC Nephrol. 2019 Oct 17;20(1):379. doi: 10.1186/s12882-019-1527-3. BMC Nephrol. 2019. PMID: 31623578 Free PMC article.
Quite a bit of this section is very technical, for example, the term "eKt/V" is often used: this is a calculation based on blood tests before and after dialysis, which measures the effectiveness of a single dialysis session in a particular patient. 2. ...Ther …
Quite a bit of this section is very technical, for example, the term "eKt/V" is often used: this is a calculation based on blood tests befor …
Intradialytic hypotension.
Gul A, Miskulin D, Harford A, Zager P. Gul A, et al. Curr Opin Nephrol Hypertens. 2016 Nov;25(6):545-550. doi: 10.1097/MNH.0000000000000271. Curr Opin Nephrol Hypertens. 2016. PMID: 27606498 Review.
Interdialytic weight gain (IDWG) 3 kg occurs more frequently among patients with IDH. Prolonged and possibly more frequent dialysis, use of biofeedback devices, dialysate cooling and limiting sodium loading are useful measures to reduce the frequency of IDH. SUMMARY …
Interdialytic weight gain (IDWG) 3 kg occurs more frequently among patients with IDH. Prolonged and possibly more frequent dialysis, …
Application of mathematical analysis on dialysis.
Miyasaka T, Sakai K. Miyasaka T, et al. J Artif Organs. 2023 Mar;26(1):1-11. doi: 10.1007/s10047-022-01359-8. Epub 2022 Sep 10. J Artif Organs. 2023. PMID: 36087159 Review.
It is now a well-established treatment, due to the improved performance of dialyzers. This review outlines the development process of dialyzers, focusing on the application based on the mathematical analysis. ...Then, currently established dialyzer des …
It is now a well-established treatment, due to the improved performance of dialyzers. This review outlines the development process of …
Personalized Management of Sodium and Volume Imbalance in Hemodialysis to Mitigate High Costs of Hospitalization.
Hornig C, Canaud BJM, Bowry SK. Hornig C, et al. Blood Purif. 2023;52(6):564-577. doi: 10.1159/000530816. Epub 2023 Jun 8. Blood Purif. 2023. PMID: 37290421 Review.
Weekly cycles imposed by the schedule of HD treatments create a deleterious and unphysiological "tide phenomenon" marked by sodium-volume overload (loading) and depletion (unloading). Fluid overload-related hospitalizations are frequent and costly, with average cost …
Weekly cycles imposed by the schedule of HD treatments create a deleterious and unphysiological "tide phenomenon" marked by sodium-volume ov …
Water quality and adverse health effects on the hemodialysis patients: An overview.
Raimundo R, Preciado L, Belchior R, Almeida CMM. Raimundo R, et al. Ther Apher Dial. 2023 Dec;27(6):1053-1063. doi: 10.1111/1744-9987.14032. Epub 2023 Jun 28. Ther Apher Dial. 2023. PMID: 37381091 Review.
Over 4 million people require some form of renal replacement therapy, with hemodialysis being the most common. ...Thus, the quality of the associated dialysis solutions is a critical issue. Accordingly, the discussion of the importance of a dialysis …
Over 4 million people require some form of renal replacement therapy, with hemodialysis being the most common. ...Thus, the qu …
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis.
Blaine E, Tumlinson R, Colvin M, Haynes T, Whitley HP. Blaine E, et al. Pharmacotherapy. 2022 Feb;42(2):177-187. doi: 10.1002/phar.2659. Epub 2022 Jan 17. Pharmacotherapy. 2022. PMID: 35000222 Review.
Chronically uncontrolled hyperglycemia is the leading cause of end stage kidney disease (ESKD) necessitating dialysis. During times of transition to hemodialysis (HD) or peritoneal dialysis (PD), considerations must be given to insulin dosing adjustments for …
Chronically uncontrolled hyperglycemia is the leading cause of end stage kidney disease (ESKD) necessitating dialysis. During times o …
Enhancing dialyser clearance-from target to development.
Tangvoraphonkchai K, Davenport A. Tangvoraphonkchai K, et al. Pediatr Nephrol. 2017 Dec;32(12):2225-2233. doi: 10.1007/s00467-017-3647-y. Epub 2017 Apr 12. Pediatr Nephrol. 2017. PMID: 28401301 Review.
As current dialysis practice effectively clears small solutes, increasing evidence supports a toxic effect for middle-sized and protein-bound toxins. Therefore, newer approaches to standard dialysis practice are required to look beyond urea clearance. …
As current dialysis practice effectively clears small solutes, increasing evidence supports a toxic effect for middle-s …
A Perspective on the Current Status of Home Hemodialysis.
Kawanishi H. Kawanishi H. Contrib Nephrol. 2018;196:171-177. doi: 10.1159/000485718. Epub 2018 Jul 24. Contrib Nephrol. 2018. PMID: 30041223 Review.
Most hemodialysis (HD) in Japan is based on the central dialysis fluid delivery system (CDDS). With CDDS, there is an improvement in work efficiency, reduction in cost, and a reduction in regional and institutional differences in dialysis conditions. . …
Most hemodialysis (HD) in Japan is based on the central dialysis fluid delivery system (CDDS). With CDDS, there is an improvem …
Whither goest Kt/V?
Gotch FA, Sargent JA, Keen ML. Gotch FA, et al. Kidney Int Suppl. 2000 Aug;76:S3-18. doi: 10.1046/j.1523-1755.2000.07602.x. Kidney Int Suppl. 2000. PMID: 10936795 Free article. Review.
Uremia is characterized by gross contamination of body water with a wide spectrum of retained solutes normally excreted by the kidney. The rationale for dialysis therapy is that these retained solutes have concentration-dependent toxicity, which can be ameliorated through …
Uremia is characterized by gross contamination of body water with a wide spectrum of retained solutes normally excreted by the kidney. The r …
7,455,786 results
You have reached the last available page of results. Please see the User Guide for more information.